{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Respimat%C2%AE+Inhaler&page=2", "query": { "intervention": "Respimat® Inhaler", "page": 2 }, "page_size": 10 }, "pagination": { "page": 2, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Respimat%C2%AE+Inhaler&page=1&page_size=10" }, "source": "remote", "last_synced_at": "2026-09-26T16:25:32.147Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00452400", "title": "Efficacy and Safety of 4 Weeks Treatment With Inhaled BI 1744 CL in Patients With COPD.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive", "Asthma" ], "interventions": [ { "name": "BI 1744CL", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 409, "start_date": "2007-03", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-27", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 22, "location_summary": "Birmingham, Alabama • Lakewood, California • Denver, Colorado + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Lakewood", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Wheat Ridge", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT00452400" }, { "nct_id": "NCT01122680", "title": "Efficacy and Safety of 3 Doses of Tiotropium Compared to Placebo in Adolescents (12 to 17 Yrs) With Moderate Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "tiotropium bromide", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 105, "start_date": "2010-05", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-05-16", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 5, "location_summary": "Denver, Colorado • Columbia, Missouri • Warrensburg, Missouri + 2 more", "locations": [ { "city": "Denver", "state": "Colorado" }, { "city": "Columbia", "state": "Missouri" }, { "city": "Warrensburg", "state": "Missouri" }, { "city": "Boys Town", "state": "Nebraska" }, { "city": "Canton", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT01122680" }, { "nct_id": "NCT01277523", "title": "Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "tiotropium high dose", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" }, { "name": "tiotropium low dose", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 392, "start_date": "2011-01", "completion_date": "2013-10", "has_results": true, "last_update_posted_date": "2014-10-20", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 8, "location_summary": "Stockton, California • Normal, Illinois • Baltimore, Maryland + 5 more", "locations": [ { "city": "Stockton", "state": "California" }, { "city": "Normal", "state": "Illinois" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Columbia", "state": "Missouri" }, { "city": "Bellevue", "state": "Nebraska" } ], "official_url": "https://clinicaltrials.gov/study/NCT01277523" }, { "nct_id": "NCT01969539", "title": "Ventilator Adapters for Combivent Respimat", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Combivent Respimat via tee adapter", "type": "DRUG" }, { "name": "Combivent Respimat via ventilator adapter", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 11, "start_date": "2013-10-14", "completion_date": "2014-11-21", "has_results": true, "last_update_posted_date": "2025-02-10", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 2, "location_summary": "Danbury, Connecticut • Fort Worth, Texas", "locations": [ { "city": "Danbury", "state": "Connecticut" }, { "city": "Fort Worth", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01969539" }, { "nct_id": "NCT00400153", "title": "Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Atrovent Respimat (20 mcg)", "type": "DRUG" }, { "name": "COMBIVENT MDI (36/206 mcg)", "type": "DRUG" }, { "name": "Combivent Respimat (20 mcg/100 mcg)", "type": "DRUG" }, { "name": "Placebo via corresponding inhaler for blinding purposes", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 1480, "start_date": "2006-11", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-13", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 87, "location_summary": "Birmingham, Alabama • Jasper, Alabama • Mobile, Alabama + 74 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Jasper", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Lakewood", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00400153" }, { "nct_id": "NCT01533935", "title": "Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "tiotropium + Olodaterol", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" }, { "name": "Olodaterol", "type": "DRUG" }, { "name": "Respimat", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 291, "start_date": "2012-02", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-09-15", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 11, "location_summary": "Phoenix, Arizona • Austell, Georgia • Baltimore, Maryland + 8 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Austell", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Saint Charles", "state": "Missouri" } ], "official_url": "https://clinicaltrials.gov/study/NCT01533935" }, { "nct_id": "NCT00720499", "title": "Efficacy and Safety of 4 Weeks of Treatment With Orally Inhaled BI1744/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease (COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "BI 1744 CL plus tiotropium bromide", "type": "DRUG" }, { "name": "Respimat® Inhaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 141, "start_date": "2008-07", "completion_date": null, "has_results": true, "last_update_posted_date": "2015-08-17", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 5, "location_summary": "Clearwater, Florida • Tampa, Florida • Philadelphia, Pennsylvania + 2 more", "locations": [ { "city": "Clearwater", "state": "Florida" }, { "city": "Tampa", "state": "Florida" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Killeen", "state": "Texas" }, { "city": "Spokane", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00720499" }, { "nct_id": "NCT01533922", "title": "Effect on Exercise Endurance and Lung Hyperinflation of Tiotropium + Olodaterol in COPD Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Tiotropium", "type": "DRUG" }, { "name": "Olodaterol", "type": "DRUG" }, { "name": "Tiotropium + Olodaterol", "type": "DRUG" }, { "name": "Respimat", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "40 Years to 75 Years" }, "enrollment_count": 295, "start_date": "2012-03", "completion_date": "2013-11", "has_results": true, "last_update_posted_date": "2015-09-15", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 8, "location_summary": "Torrance, California • Hartford, Connecticut • Livonia, Michigan + 5 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Hartford", "state": "Connecticut" }, { "city": "Livonia", "state": "Michigan" }, { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Easley", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01533922" }, { "nct_id": "NCT00128440", "title": "High Dose Trial in COPD", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "BEA 2180 BR", "type": "DRUG" }, { "name": "tiotropium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": "84 Years", "sex": "ALL", "summary": "40 Years to 84 Years" }, "enrollment_count": 78, "start_date": "2005-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2013-10-29", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 13, "location_summary": "Lakewood, California • Wheat Ridge, Colorado • Pembroke Farms, Florida + 10 more", "locations": [ { "city": "Lakewood", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Pembroke Farms", "state": "Florida" }, { "city": "Coeur d'Alene", "state": "Idaho" }, { "city": "Reno", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT00128440" }, { "nct_id": "NCT00696020", "title": "Combination of Orally Inhaled BI1744CL/Tiotropium Bromide in Patients With Chronic Obstructive Pulmonary Disease ( COPD)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pulmonary Disease, Chronic Obstructive" ], "interventions": [ { "name": "BI 1744 CL/tiotropium bromide fixed dose combination", "type": "DRUG" }, { "name": "tiotropium bromide", "type": "DRUG" }, { "name": "Respimat® Inhaler", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "40 Years", "maximum_age": null, "sex": "ALL", "summary": "40 Years and older" }, "enrollment_count": 360, "start_date": "2008-06", "completion_date": null, "has_results": true, "last_update_posted_date": "2015-08-13", "last_synced_at": "2026-09-26T16:25:32.147Z", "location_count": 22, "location_summary": "Riverside, California • San Diego, California • Wheat Ridge, Colorado + 18 more", "locations": [ { "city": "Riverside", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Wheat Ridge", "state": "Colorado" }, { "city": "Clearwater", "state": "Florida" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00696020" } ] }